Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

. 2017 Mar ; 2 (1) : 46-53. [epub] 20161115

Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid30886901

Grantová podpora
MR/N003403/1 Medical Research Council - United Kingdom

Odkazy

PubMed 30886901
PubMed Central PMC6377059
DOI 10.1177/2396987316679577
PII: 10.1177_2396987316679577
Knihovny.cz E-zdroje

INTRODUCTION: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences in patients with acute stroke and atrial fibrillation, regarding risk factors, treatments received and outcomes. METHODS: Data were analyzed from the "Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation" (RAF-study), a prospective, multicenter, international study including only patients with acute stroke and atrial fibrillation. Patients were followed up for 90 days. Disability was measured by the modified Rankin Scale (0-2 favorable outcome, 3-6 unfavorable outcome). RESULTS: Of the 1029 patients enrolled, 561 were women (54.5%) (p < 0.001) and younger (p < 0.001) compared to men. In patients with known atrial fibrillation, women were less likely to receive oral anticoagulants before index stroke (p = 0.026) and were less likely to receive anticoagulants after stroke (71.3% versus 78.4%, p = 0.01). There was no observed sex difference regarding the time of starting anticoagulant therapy between the two groups (6.4 ± 11.7 days for men versus 6.5 ± 12.4 days for women, p = 0.902). Men presented with more severe strokes at onset (mean NIHSS 9.2 ± 6.9 versus 8.1 ± 7.5, p < 0.001). Within 90 days, 46 (8.2%) recurrent ischemic events (stroke/TIA/systemic embolism) and 19 (3.4%) symptomatic cerebral bleedings were found in women compared to 30 (6.4%) and 18 (3.8%) in men (p = 0.28 and p = 0.74). At 90 days, 57.7% of women were disabled or deceased, compared to 41.1% of the men (p < 0.001). Multivariate analysis did not confirm this significance. CONCLUSIONS: Women with atrial fibrillation were less likely to receive oral anticoagulants prior to and after stroke compared to men with atrial fibrillation, and when stroke occurred, regardless of the fact that in our study women were younger and with less severe stroke, outcomes did not differ between the sexes.

2nd Department of Neurology Attikon Hospital University of Athens School of Medicine Athens Greece

Abteilung für Neurologie Oberschwabenklinik gGmbH Ravensburg Germany

Centre Cerebrovasculaire Service de Neurologie Department des Neurosciences Cliniques Centre Hopitalier Universitaire Vaudois Lausanne Switzerland

Clinica Neurologica Azienda Ospedaliero Universitaria Pisa Italy

Department of Clinical and Experimental Sciences Neurology Unit University Health and Wealth of Brescia Italy

Department of Internal Medicine Cecina Hospital Cecina Livorno Italy

Department of Internal Medicine Insubria University Varese Italy

Department of Internal Medicine Ospedale Civile di Piacenza Italy

Department of Neurology and Psychiatry Sapienza University of Rome Italy

Department of Neurology Bogomolets National Medical University Kyiv Ukraine

Department of Neurology Born Bunge Institute Antwerp University Hospital Antwerp Belgium

Department of Neurology Democritus University of Thrace University Hospital of Alexandroupolis Greece

Department of Neurology Dresden University Stroke Center Dresden Germany

Department of Neurology Helsinki University Central Hospital Helsinki Finland

Department of Neurology Keimyung University School of Medicine Daegu South Korea

Department of Neurology Sahlgrenska University Hospital Gothenburg Sweden

Department of Neurology University of L'Aquila Italy

Institute of Neuroscience and Physiology Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden

International Clinic Research Center St Anne's University Hospital Brno Brno Czech Republic

Medical School and Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow United Kingdom

Municipal Budgetary Healthcare Institution of Novosibirsk City Clinical Hospital Novosibirsk Russia

Neurologia d'urgenza e Stroke Unit Istituto Clinico Humanitas Rozzano Milano Italy

Neurology Hamad Medical Corporation Doha Qatar

SSO Stroke Unit UO Neurologia DAI di Neuroscienze AOUI Verona Italy

Stroke Unit and Division of Cardiovascular Medicine University of Perugia Italy

Stroke Unit AOU Senese Siena Italy

Stroke Unit Department of Neurology Sant'Andrea Hospital La Spezia Italy

Stroke Unit Department of Neurology Santa Corona Hospital Pietra Ligure Italy

Stroke Unit Dipartimento Geriatrico Riabilitativo University of Parma Italy

Stroke Unit Jazzolino Hospital Vibo Valentia Italy

Stroke Unit Neurology Insubria University Varese Italy

Stroke Unit Neuroscience Department University of Parma Italy

Stroke Unit Ospedale Civico Palermo

Stroke Unit Ospedale di Portogruaro Portogruaro Venice Italy

Stroke Unit University of Debrecen Hungary

UO Gravi Cerebrolesioni San Giovanni Battista Hospital Foligno Italy

Zobrazit více v PubMed

Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009; 40: 235–240. PubMed

Saposnik G, Gladstone D, Raptis R, et al. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke 2013; 44: 99–104. PubMed

Hart RG, Pearce LA, Aguilar MI. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–867. PubMed

Bushnell C, McCullough L. Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association Guideline. Ann Intern Med 2014; 160: 853–857. PubMed PMC

Cove CL, Albert CM, Andreotti F, et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014; 111.3: 385–391. PubMed

Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation 2005; 112: 1687–1691. PubMed PMC

Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010; 137: 263–272. PubMed

Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572–577. PubMed

Jespersen SF, Christensen LM, Christensen A, et al. Use of oral anticoagulation therapy in atrial fibrillation after stroke: results from a nationwide registry. Thrombosis 2013; 7 p., 10.1155/2013/601450 (accessed 25 September 2013). PubMed DOI PMC

Paciaroni M, Agnelli G, Falocci N, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation. effect of anticoagulation and its timing: The RAF Study. Stroke 2015; 46: 2175–2182. PubMed

Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008; 39: 2249–2256. PubMed

Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR 1993; 14: 3–13. PubMed PMC

Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of human brain: brainstem and cerebellum. Neurology 1996; 47: 1125–1135. PubMed

Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998; 50: 1699–1708. PubMed

Reboldi G, Angeli F, Verdecchia P. Mutivariable analysis in cerebrovascular research: practical notes for the clinician. Cerebrovasc Dis 2013; 35: 187–193. PubMed

Kapral MK, Fang J, Hill MD, et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809–814. PubMed

Santalucia P, Pezzella FR, Sessa M, et al. Sex differences in clinical presentation, severity and outcome of stroke: Results from a hospital-based registry. EJIM 2013; 24: 167–171. PubMed

Gattringer T, Ferrari J, Knoflach M, et al. Sex related differences of acute stroke unit care: results from the Austrian Stroke Unit Registry. Stroke 2014; 45: 1632–1638. PubMed

Gómez-Doblas JJ. Valvular heart disease in women: sex differences in Spain. Rev Esp Cardiol 2010; 8: 42–48.

Wang D, Liu M, Hao Z, et al. Features of acute ischemic stroke with rheumatic heart disease in a hospitalized Chinese population. Stroke 2012; 43: 2853–2857. PubMed

Eriksson M, Glader EL, Norrving B, et al. Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke 2009; 40: 900–914. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...